Lyell Immunopharma, Inc. (LYEL)

NASDAQ: LYEL · Real-Time Price · USD

20.41

-0.72 (-3.41%)

Mar 17, 2026, 12:24 PM EDT - Market open

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Biotechnology		61.00K	130.00K	84.68M	10.65M	7.76M
Biotechnology Growth		-53.08%	-99.85%	695.15%	37.31%	1080.52%
Total		61.00K	130.00K	84.68M	10.65M	7.76M
Total Growth		-53.08%	-99.85%	695.15%	37.31%	1080.52%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States		61.00K	130.00K	84.68M	10.65M	7.76M
United States Growth		-53.08%	-99.85%	695.15%	37.31%	1080.52%
Total		61.00K	130.00K	84.68M	10.65M	7.76M
Total Growth		-53.08%	-99.85%	695.15%	37.31%	1080.52%

Source: S&P Global Market Intelligence.